Antonio Hernandez
Internal Medicine · Goose Creek, SCNPI 1871577460
Payments from drug & device makers
Across 431 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$875
- Novo Nordisk$818
- AbbVie$705
- Johnson & Johnson$547
- Sanofi-aventis U.S. LLC$363
- Lilly USA, LLC$340
- plus $4K from 36 others
What the payments were for
- Food & beverage$7,34998%
- Education$1122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$121
How this compares
$7,461 in reported general payments places this provider in the 90th percentile of 1,498 internal medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 201 | $31,629 |
| XifaxanRifaximin | 25 | $21,181 |
| Atorvastatin Calcium | 573 | $6,725 |
| Donepezil Hcl | 273 | $4,226 |
| Amlodipine Besylate | 586 | $4,097 |
| Omeprazole | 228 | $3,808 |
| Pravastatin Sodium | 306 | $3,667 |
| Levetiracetam | 290 | $3,491 |
| Tamsulosin Hcl | 395 | $3,400 |
| MyrbetriqMirabegron | 26 | $3,113 |
| Potassium Chloride | 379 | $2,777 |
| Topiramate | 101 | $2,128 |
| Montelukast Sodium | 142 | $1,992 |
| Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone | 52 | $1,915 |
| Ezetimibe | 152 | $1,893 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $301 | $31,629201 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $149 | $21,18125 claims |
| Astellas Pharma US IncMyrbetriq | $238 | $3,11326 claims |
| Upsher-smith Laboratories LLCTopiramate | $36 | $2,128101 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Goose Creek
- Rica SantiagoMt Pleasant$10.7M
- Richard MillsMt Pleasant$5.5M
- Yvonne DavisMount Pleasant$2.4M
- David BolsterSummerville$2.3M
- Colby GrossmanSummerville$1.4M
- Amit ShahIndian Land$1.4M
- Philip NicolMurrells Inlet$782K
- Carl SofleyAnderson$673K
- Carl MitchellColumbia$564K
- Jerry BackNorth Charleston$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.